Aktuellt
SENASTE
Redeye comments on today’s news regarding the updated goals for 2022. We are encouraged to learn that aXichem intends to enter into a framework agreement with a large European feed producer during next year and believe that this is a good strategy to establish aXiphen-feed as a standard ingredient in animal feed. We reiterate our Base Case and continue to see the stock as attractive for the long-term investor.
LÄS MER
